Why some thyroid biopsy samples are hard to evaluate quickly
Part of Cancer, Hormones & metabolism clinical trials.
This trial looks at what makes it harder to quickly tell if a thyroid nodule sample is good enough for diagnosis during your biopsy. It may help doctors improve the procedure for people with suspicious nodules.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for a fine needle aspiration (FNA) biopsy of a thyroid nodule.
- Your nodule is classified as TIRADS 3, 4, or 5 (moderate to high suspicion for cancer).
- You have not had any previous thyroid ablation treatment (like alcohol or heat therapy) on that nodule.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how doctors talk with patients who have a thyroid nodule that may need a biopsy. It aims to improve communication and help patients feel more involved in their care.
This study tests a new tool (ThyroidPrint) to see if it can accurately predict whether a thyroid nodule with unclear biopsy results is benign or malignant. The goal is to help doctors and patients decide on surgery more confidently.
This study looks at your thyroid nodule to better understand if it might be cancer. They use your medical history, ultrasound, and special tests to help figure out the risk, which may help you make decisions about treatment.
This study looks at whether testing a piece of the removed thyroid nodule during surgery (called a frozen section) can help tell if a growth is benign or cancerous. It may help patients get more accurate information right after their surgery.
This study checks how accurate a fine needle aspiration (a small needle test) is for diagnosing thyroid nodules. If you are having thyroid surgery, your test results will be compared with the final surgical biopsy to see how well they match.
This study uses artificial intelligence (AI) to look at ultrasound images and cell samples from thyroid nodules that had an unclear biopsy result. The goal is to see if AI can better tell which nodules are cancerous, helping avoid unnecessary surgery in the future.
Hear when a new Thyroid Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.